| Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016 (PR Newswire) Inverness Medical Innovations, Inc. announced today that it has extended its offer to exchange up to $100,000,000 in aggregate principal amount of 7.875% Senior Notes due 2016 that have been registered under the Securities Act of 1933, as amended, for a like principal amount of its outstanding unregistered 7.875% Senior Notes due 2016, to 5:00 p.m., New York City time, on Friday, June 4, 2010, unless further extended. us.rd.yahoo.com |
Cephalon Breaks the Downtrend Stone Fox Capital submits:After falling non-stop since the end of March, it finally appears that the downtrend has been broken in Cephalon (CEPH). Since closing at a high of $72.10 on March 23rd, CEPH has continuously remained below the 10ema all the way to several days trading at $56. Tuesday the stock not only handily zoomed above the 10ema but also the 20ema, signalling a clear change of direction.Stone Fox Capital added it to the Opportunistic and Growth Portfolios a few weeks back, around the closing range of $59. Clearly we got on board a few weeks too early, but the price was too compelling at now just 8x next year. Also, it was an opportunity to build up some biotech exposure after the healthcare reform was finalized.Complete Story » seekingalpha.com |
FDA Issues Warning On Anti-Seizure Drug The FDA said Glaxo's Lamictal, used to treat seizures in children, can cause aseptic meningitis, an inflammation of the protective membranes that cover the brain and spinal cord. online.wsj.com |
New Clue in Heart Disease Researchers have discovered a mysterious protein in cells of people as they age and are examining its role in heart disease. online.wsj.com |
Biogen Profit Drops 8.5%; MS Drugs Help Revenue Biogen Idec's third-quarter earnings dropped 8.5%, weighed down by charges, as revenue rose 5% on continued growth of the company's core multiple-sclerosis franchise. online.wsj.com |